BPA Call 75F40119A10014-75F40123F19003
- The U.S. Food and Drug Administration (FDA) awarded a $1,652,153.25 Blanket Purchase Agreement (BPA) call to AB Sciex LLC, a division of Danaher Corporation. The contract provides for the acquisition of three triple quadrupole mass spectrometers, three high-performance liquid chromatography (HPLC) systems, and three nitrogen generators. This award is under the FDA's Multiple Award Schedule (MAS) contract vehicle and has a firm fixed-price pricing structure. The contract has a completion date...
- <p>The Food and Drug Administration issued a BPA call to Thermo Electron North America LLC for two HRMS-UHPLC systems including Orbitrap Exploris 120 mass spectrometers and Vanquish Horizon binary UHPLC systems, plus one nitrogen generator, with a ceiling value of $830,588.14, awarded September 7, 2023. The call was issued under the GSA Multiple Award Schedule (MAS). Place of performance is Jamaica, New York. The ultimate completion date is September 6, 2024. Pricing is firm fixed price.</p>
- The Food and Drug Administration issued a BPA call to Agilent Technologies Inc. on July 15, 2026, with a ceiling value of $36,934.66 for one Agilent 1260 Infinity III high-performance liquid chromatography (HPLC) system. The call is placed under the GSA Multiple Award Schedule. Place of performance is Jamaica, New York 11433, with an ultimate completion date of September 19, 2026. The call is firm fixed price and procures a single analytical laboratory instrument with associated delivery and...
- The Food and Drug Administration awarded a definitive firm fixed price contract to AB Sciex LLC, a division of Danaher Corporation, for the purchase of AB Sciex ZenoTOF 7600+ and 4500 QTRAP liquid chromatography-tandem mass spectrometry (LC-MS/MS) systems. The contract, valued at $1.05M, was competitively awarded without set-aside designation and is scheduled for completion by September 18, 2026. The equipment will be delivered to the FDA's facility in Silver Spring, Maryland, where it will...
- The Food and Drug Administration issued a $464,854.20 delivery order to AB Sciex LLC on September 7, 2023, for ultra-sensitive liquid chromatograph/triple quadrupole mass spectrometers with ion-trap capabilities. The order is issued under the GSA Multiple Award Schedule (MAS), which provides access to analytical instrumentation and laboratory equipment across federal agencies. Place of performance is Lenexa, KS 66214. Ultimate completion is December 6, 2023. AB Sciex, a division of Danaher...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price blanket purchase agreement call against the Scientific Equipment and Services GSA Schedule to AB Sciex LLC for the delivery of fifteen liquid chromatography/triple quadrupole mass spectrometers with HPLC. Valued at up to four million three hundred twenty-four thousand eight hundred twenty-two dollars and ninety-seven cents ($4,324,822.97), this contract supports the FDA's testing and research...
- The Department of Health and Human Services Food and Drug Administration awarded a $207,390.35 firm fixed-price delivery order to AB Sciex LLC, a division of Danaher Corporation, for a hybrid triple quadrupole-linear ion trap mass spectrometer. The contract includes delivery, installation, training, and warranty. This order is part of a broader set of Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicles that AB Sciex LLC holds with the FDA to provide specialized liquid...
- The Department of Health and Human Services Food and Drug Administration awarded a $4.5 million firm fixed price blanket purchase agreement call contract to AB Sciex LLC, a division of Danaher Corporation, to deliver twelve liquid chromatography-quadrupole-quadrupole mass spectrometry systems and four nitrogen generators. The products will support the FDA's regulatory science and laboratory programs. AB Sciex will draw upon its GSA Multiple Award Schedule contract vehicle to fulfill the order....
- AB Sciex LLC was awarded a firm fixed price contract valued at $748,962.89 by the Department of Health and Human Services' Food and Drug Administration to purchase two ultra-sensitive liquid chromatography/triple quadrupole mass spectrometers with ion-trap capabilities and one nitrogen generator. The award was made under the company's existing Blanket Purchase Agreement with the FDA, which allows for the delivery of such analytical instrumentation through 2025 in support of the agency's...
- This is a firm fixed-price delivery order awarded to AB Sciex LLC, a division of Danaher Corporation, by the Department of Health and Human Services Food and Drug Administration. The contract is for the delivery of a hybrid triple quadrupole linear ion trap mass spectrometer system, which supports the FDA's regulatory science and public health protection programs through specialized laboratory testing and research capabilities. The potential value of the contract is $479,701.44 and the...
- Multiple Award Schedule (MAS)Master GSA Schedule
- GS07F0092X-75F40119A10014Blanket Purchase Agreement
- 75F40119A10014-75F40123F19003BPA Call
The Food and Drug Administration issued a BPA call to AB Sciex LLC on June 20, 2023, for liquid chromatograph/triple quadrupole mass spectrometers with HPLC, with a ceiling value of $287,136.28 and ultimate completion date of September 29, 2024. The call was issued under a $19.9 million Blanket Purchase Agreement with the FDA under the General Services Administration's Multiple Award Schedule, through which AB Sciex is authorized to supply triple quadrupole mass spectrometers, HPLC systems, ultra-high-performance liquid chromatography systems, wide-range diode array detectors, and nitrogen generators, including delivery, installation, and maintenance services to support the FDA's regulatory science and public health protection programs. Performance will take place in Jamaica, New York. The contract is firm fixed price with no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $287.1k | 6/19/23 |